Topic: BIOVAXYS
8 results were found.
BioVaxys Sarbecovirus vaccine interim data excellent emerging safety and tolerability profile with BVX-1021 - November 18, 2022
BioVaxys executes agreement for U.S. distribution for Papilocare gel and oral Immunocaps - October 7, 2022
BioVaxys announces completed synthesis of its pan-sarbecovirus vaccine candidate, launch of in vivo animal study - September 7, 2022
BioVaxys announced production of BVX-1021 for SARS1 with Ohio State University - March 18, 2022
BioVaxys files U.S. patent application for pan sarbecovirus vaccine - October 21, 2021
BioVaxys prepares for groundbreaking study on SARS-CoV-2 proteins - September 24, 2021
BioVaxys cancer vaccine manufacturing partner Bio Elpida reaches bioproduction milestone - September 17, 2021
BioVaxys receives positive FDA response for Pre-IND review for CoviDTH clinical development - June 15, 2021